As shown in Table 2, CCL5 immunoreactivity was not correlated with any clinicopathological factors in the CCR1-positive group (n = 21), while it was negatively correlated with pathological T factor (pT) (p = 0.037) and lymph node metastasis (p = 0.024) in the CCR5-positive group (n = 45). This evidence concerns the gene CCR5 and metastatic malignant neoplasm in the lymph nodes.